CNBC' s Josh Brown urged viewers to buy this right in front of the quarterly report. At least ithat call was not as bad as his call last year that everything in biotech was un investable because anything of value would have been bought already. Pathetic!
What are the debt covenants here? If balance sheet inventory is understated, then cash is overstated. This would mean they may not have enough cash to cover short term debt repayment due.